AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SEED INNOVATIONS LIMITED

Report Publication Announcement Nov 13, 2025

7909_rns_2025-11-13_ee877a6f-92ed-4c6a-8dbc-e889142ed17c.html

Report Publication Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4340H

Seed Innovations Limited

13 November 2025

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

REACH Announcement

13 November 2025

SEED Innovations Limited

("SEED" or the "Company")

Investee Company Update: Little Green Pharma Ltd

SEED Innovations Ltd, the AIM-quoted investment company, is pleased to note that its portfolio company, Little Green Pharma Ltd ("LGP"), has published its Quarterly Activities Report and Appendix 4C for the period ending 30 September 2025 on the ASX along with an accompanying Investor Presentation.

SEED holds 7,324,796 ordinary shares in LGP, representing approximately 2.4% of LGP's issued share capital.

The Quarterly Activities Report and Investor Presentation can be accessed via the following links:

·    https://investlittlegreenpharma.com/site/investor-centre/quarterly-reports1

·    https://investlittlegreenpharma.com/site/pdf/968c019f-f36e-433f-92b8-a3061804ad07/September-2025-Quarterly-Appendix-4C-Investor-Presentation.pdf?Platform=ListPage

- Ends -

For further information on the Company please visit: www.seedinnovations.co or contact: 

Lance de Jersey SEED Innovations Ltd E: [email protected]
James Biddle 

Roland Cornish
Beaumont Cornish Limited, 

Nomad
T: (0)20 7628 3396
Isabella Pierre 

Damon Heath
Shard Capital Partners LLP 

Broker
T: (0)20 7186 9927
Ana Ribeiro

Isabel de Salis
St Brides Partners Ltd, 

Financial PR
E: [email protected]

NOTES 

Seed Innovations Ltd 

SEED Innovations Ltd (SEED.L) is an AIM-quoted investment company focused on providing access to high-growth robotics and AI ventures typically beyond the reach of everyday investors. The Company also oversees a legacy portfolio in wellness and life sciences, with a medium-term strategy to unlock its full value. Back by an experienced team and strong cash reserves, the Company remains agile and well-positioned to capitalise on new investment opportunities as they arise.

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAGPGCUGUPAGUW

Talk to a Data Expert

Have a question? We'll get back to you promptly.